Artesunate Inhibits Metastatic Potential in Cisplatin-Resistant Bladder Cancer Cells by Altering Integrins

The survival of patients with locally advanced and metastatic bladder cancer (BCa) is persistently low. Hence, new treatment options are urgently needed. Artesunate (ART) a derivative of artemisinin, used in Traditional Chinese Medicine, shows anti-tumor activity extending over a broad spectrum of h...

Full description

Bibliographic Details

Published in:	Cells
Main Authors:	Olesya Vakhrusheva, Fuguang Zhao, Sascha Dennis Markowitsch, Kimberly Sue Slade, Maximilian Peter Brandt, Igor Tsaur, Jindrich Cinatl, Martin Michaelis, Thomas Efferth, Roman Alexander Blaheta, Axel Haferkamp, Eva Juengel
Format:	Article
Language:	English
Published:	MDPI AG 2025-04-01
Subjects:	bladder cancer (BCa) artesunate (ART) cisplatin resistance adhesion chemotaxis migration
Online Access:	https://www.mdpi.com/2073-4409/14/8/570